These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2907468)

  • 21. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
    Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
    Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
    Dalton JT; Meyer MC; Golub AL
    Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of N-nitrosodimethylamine in beagles.
    Gombar CT; Pylypiw HM; Harrington GW
    Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans.
    Matsushima H; Kamimura H; Soeishi Y; Watanabe T; Higuchi S; Tsunoo M
    Drug Metab Dispos; 1998 Mar; 26(3):240-5. PubMed ID: 9492387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsant activity of four oxygenated cannabidiol derivatives.
    Carlini EA; Mechoulam R; Lander N
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):1-15. PubMed ID: 1188178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
    Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of single-dose administration of tinidazole in unweaned calves.
    Pyörälä S; Soback S; Rainio V; Silvennoinen P; Nokelainen M
    Am J Vet Res; 1994 Jun; 55(6):831-4. PubMed ID: 7944024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
    Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
    Usui T; Watanabe T; Higuchi S
    Drug Metab Dispos; 1995 Nov; 23(11):1214-9. PubMed ID: 8591721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.